Page last updated: 2024-11-01

ondansetron and Diathesis

ondansetron has been researched along with Diathesis in 3 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research Excerpts

ExcerptRelevanceReference
"Ondansetron is currently being explored as a treatment for motion sickness due to its proven prophylactic effect on post-operative nausea, the nausea and vomiting associated with chemotherapy, and its lack of side effects."9.12High dose ondansetron for reducing motion sickness in highly susceptible subjects. ( Elkins, AN; Muth, ER, 2007)
"Ondansetron is currently being explored as a treatment for motion sickness due to its proven prophylactic effect on post-operative nausea, the nausea and vomiting associated with chemotherapy, and its lack of side effects."5.12High dose ondansetron for reducing motion sickness in highly susceptible subjects. ( Elkins, AN; Muth, ER, 2007)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumar, N1
Hu, WT1
Johannsen, S1
Roewer, N1
Schuster, F1
Muth, ER1
Elkins, AN1

Trials

1 trial available for ondansetron and Diathesis

ArticleYear
High dose ondansetron for reducing motion sickness in highly susceptible subjects.
    Aviation, space, and environmental medicine, 2007, Volume: 78, Issue:7

    Topics: Adolescent; Adult; Analysis of Variance; Antiemetics; Dimenhydrinate; Disease Susceptibility; Dose-R

2007

Other Studies

2 other studies available for ondansetron and Diathesis

ArticleYear
Extrapyramidal reaction to ondansetron and propofol.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Jan-30, Volume: 24, Issue:2

    Topics: Adult; Anesthesia Recovery Period; Anesthetics, Intravenous; Antiemetics; Basal Ganglia Diseases; Di

2009
Ondansetron-induced muscular contractures in malignant hyperthermia-susceptible individuals.
    Anesthesia and analgesia, 2012, Volume: 115, Issue:4

    Topics: Adult; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Humans; Male; Malignant Hyp

2012